Ruti Aga and the fake prescription: Six years erased over an old prescription pad

The clinic on that piece of paper never existed. The person who signed it called themselves a doctor, but had no medical registration number. And the pad the prescription was written on — according to the explanation given by that same person — was an old pad taken from a former workplace, at a medical facility whose personnel records confirmed this person had never set foot there. Three small details, lined up next to each other, were enough to turn a two-year sanction into six. And enough to end the career of one of the world's leading women marathoners, at precisely the age when she could still earn the most. We always think we know everything, until a strange name pushes the door open. But this time the name is not strange. Ruti Aga. The woman who won the 2026 Tokyo Marathon. The woman who finished runner-up three times at the biggest marathons on the planet. An Ethiopian athlete, 32 years old, at the peak of her career, banned for six years over a fake prescription written by a member of her own family. This is not a story about doping. It is a story about a small mistake covered up by a larger one, and about a support system that abandoned an athlete at the exact moment she needed it most. I once mispronounced a person's name. The world kept turning. But their story cannot be misread a second time. And Aga's story, if read only through the headline "marathon runner banned six years for doping," has been misread from the very start. Let us begin again from the beginning, slowly, the way one opens an old file. Ruti Aga was born in Ethiopia, raised in a country where women's marathon is not a minor sport — it is an industry, a national pride, a machine that produces athletes the whole world respects. In 2026, she won the Tokyo Marathon. That is no small race. It is one of the six largest marathons in the world, where the top names gather and where every victory comes with a not-insignificant cheque, plus appearance invitations worth tens of thousands of dollars per start. She was not the top star of women's marathon — that title belonged to names like Brigid Kosgei or Ruth Chepngetich — but she belonged to the genuine elite: someone who could stand on the podium at any major marathon, on any given day. Three runner-up finishes at major marathons. That number says a lot about an athlete. It says she was not a one-time lucky winner who then disappeared. It says she was consistently in the lead pack, consistently able to withstand the pressure of races lasting two and a half hours, consistently the kind of name race organizers want on the start list. In the marathon world, consistency at the highest level is worth more than a lucky victory. And Aga had that consistency. Then came March. A half marathon in China. She won. No one published the specific time of that race in the case file — and that is a detail worth noticing, because it suggests this was not a race remembered for its statistics, but for another reason. After the race, she was drug-tested. Her sample came back positive for methylprednisolone. That is where the story begins, and also where it was misunderstood from the very starting point. I have read a great many articles about this case. And what bothered me most was not the sanction. It was the way the articles named the substance. Almost all of them wrote "steroid" — a muscle-growth hormone, the thing the public associates with dark gyms and bodybuilders. But methylprednisolone is not an anabolic steroid. It is a synthetic glucocorticoid — a corticosteroid, an anti-inflammatory, pain-relieving class of drug commonly used to treat arthritis, tendonitis, and knee injuries. This is no small distinction. In WADA's classification system, methylprednisolone sits in class S9 — glucocorticoids. And most importantly: it is prohibited only in-competition, not out-of-competition. It is also a "Specified Substance" — a category reserved for substances more plausibly linked to inadvertent or therapeutic use, rather than performance enhancement. For this reason, the baseline sanction for a positive test of this kind is usually two years, and can be reduced or even waived if the athlete proves a legitimate therapeutic purpose. I emphasise this because it changes the entire way the case should be read. If Aga genuinely had a knee injury and was genuinely treated with methylprednisolone, this could have been a completely different story — the story of an athlete who took medication correctly but lacked paperwork, or took it at the wrong time. That is a fixable mistake. That is precisely why the TUE exists — the Therapeutic Use Exemption, the document that allows an athlete to use a prohibited substance for legitimate medical reasons. But Aga had no TUE. And instead of applying for one, or admitting a medical error, she — or someone around her — chose another path. This is the part I need to tell slowly. Because it is the heart of the case. When asked to explain the source of the prohibited substance, Aga produced a prescription. The document stated that she had been prescribed methylprednisolone to treat a knee injury, by a doctor at a clinic. It sounded plausible. The knee injury was real — at least according to her statement. Treatment with corticosteroids is normal in sport. Everything seemed to fit. Until the Athletics Integrity Unit — World Athletics' independent integrity body, the authority that handled the entire case — began to verify. They contacted the clinic named on the prescription. The clinic replied: we do not exist. More precisely, there was no such clinic at that address, and the prescription was not issued by them. They confirmed the prescription was not theirs. That was the first step. The second step: the person who signed the prescription, claiming to be a doctor, turned out to be a relative of Aga's. This person had no medical registration number. No licence. No legal standing to prescribe to anyone. The third step — and this is the detail that made me stop: when asked about the prescription pad, this person stated they had used an old pad from a former workplace. The authorities checked that workplace. They confirmed: this person had never worked there. Three layers of verification. Three exposures. A lie constructed from fragments so clumsy it is hard to believe, dismantled in just a few basic checks. This was not a sophisticated doping conspiracy. It was an amateur cover-up, carried out by people with no understanding whatsoever of how sports integrity processes work. And that very amateurism is the most valuable evidence of a real gap. Look at the numbers. Two years for the presence of a prohibited substance. Four years for tampering with evidence. Total: six years. Under the WADA Code, when an athlete commits multiple violations, the sanctions are served consecutively, not concurrently. That means the four years for tampering did not replace the two years for the substance violation — it was added on top. And here is what I want you to remember: the penalty for fabricating documents is double the penalty for using the substance. In WADA's system, the cover-up is punished more heavily than the original act. This is not random cruelty. It is a deliberate choice, and it reflects a very clear philosophy: sport can forgive a mistake, but it cannot forgive a lie. An athlete who takes the wrong medication is a person who made an error. An athlete who invents a story to hide the error is a person who breaks the very foundation of the system — the belief that competitive results are real. But there is a paradox here I cannot ignore. If the substance was a Specified Substance — a category designed to protect those who use medication for therapeutic purposes — why did Aga not take the legitimate path? Why not apply for a retrospective TUE? Why not admit: "My knee hurt, I was given a corticosteroid injection, I did not know it was prohibited in-competition"? The answer, I think, lies elsewhere. Not in the nature of the substance, but in the support structure around an Ethiopian distance runner. I have followed the East African marathon world for more than nineteen years. I have seen young athletes emerge from the highlands of Bekoji or Asella with bare feet and undeniable talent. I have also seen them pulled into an economic machine where, between a management contract, an appearance slot and a long-haul flight, there is no room for a lawyer specialising in anti-doping. No room for a workshop on TUEs. No room for the question: "If I get hurt, what is the right thing to do?" When you are an athlete earning hundreds of thousands of dollars a year from road races in Asia and Europe, you have an agent who handles flights and hotels. You have a coach who handles training plans. You have a support team handling nutrition, recovery, physiotherapy. But no one — often no one — handles your integrity-process advice. And at the most critical moment of your life, when a letter from the AIU arrives and you must respond within days, who do you call? Aga called her family. And her family did the worst possible thing: they helped her invent a story. I do not write this to defend her. Falsifying documents is wrong, and a four-year sanction is proportionate to that act. But I write to point out that: a functioning support system could have produced an entirely different outcome. If Aga had had a lawyer who understood the WADA Code, that person would have told her: "Don't fabricate. Admit it. Apply for a retrospective TUE. Prove this was medical treatment, not performance enhancement." With a class-S9 substance, prohibited only in-competition, and a Specified Substance at that, a legitimate path could have brought the sanction down to zero, or at most a few months. Instead, she walked out with six years. There is a belief I have always held in this profession, after nearly twenty years watching women athletes pass through glory and defeat: the story of injury and comeback is never a story about the body. It is a story about the people behind the athlete — the people who control information, control the schedule, control how an athlete appears before the public. When an athlete says "I'll be back by the end of the week," it usually means the injury has not healed and the communications team is buying time. Aga's case is the extreme version of that principle: when an athlete faces a legal crisis, the team around her controls how she responds. And that team controlled it very badly. Look at the bigger picture for a moment. The Chinese half marathon where she tested positive — that was not a world championship, not an Olympic Games, not a heavily televised event. It was one of hundreds of road races in China, where organizers invite East African athletes to raise the prestige of the race and attract mass-participation runners. This is a real economy: Ethiopian and Kenyan athletes fly to Asia, run a few races over a few weeks, collect appearance fees and prize money, then go home. It works financially. But it also creates an environment where athletes move constantly, rarely have stable medical oversight, and often improvise their way through minor health problems. A sore knee after a race. A painkilling injection at a local clinic. A drug test a few days later. And a positive result for a substance the athlete may not have known was prohibited in-competition. This is a scenario I have seen repeat, at varying levels. And it does not happen only to women athletes, but for women athletes in sports with less investment in legal support, it happens more often. That is why I always say: do not look at the positive test number. Look at the circumstances that led to it. But wait. I do not want you to think I am turning Aga into a victim. She is not the victim of a conspiracy. She is someone who made a choice — or at least agreed to a choice — to falsify evidence. And that choice has consequences. This is the hardest balance in the story: on one hand, she is the product of a weak support system; on the other, she remains responsible for her own conduct. The two are not mutually exclusive. They coexist. And that is also why I do not want this story simplified into "an athlete caught doping." Because if that is all it is, we will miss the most important thing: where the system failed, and how to keep it from failing the next person. Let us talk about age. Aga is 32. In women's marathon, peak form commonly extends to around 35, sometimes beyond. That means she was at the late end of her peak — not past it, but drawing on the best years she had left. A six-year ban, running from 10 September, would return her to eligibility at nearly 38. In theory, a female marathoner can compete at the highest level into her late 30s. But after six years without racing, without testing, without the friction of the elite environment, the probability of returning to a major-marathon podium is close to zero. This is not a temporary sanction. It is a career death sentence, sealed by an old prescription pad. I have watched many athletes return from bans. But most were short — a few months, a year, sometimes two. Six years is a different category of time. It is not just losing six seasons. It is losing six years of a body at its most capable, six years of sponsor relationships, six years of appearance invitations, six years of a position in the marathon world she had worked hard to build. And here is what I want to emphasise, because it is often overlooked in doping articles: the commercial value of an elite women marathoner is not in prize money. It is in appearance fees — the money organizers pay to have a name on the start list. An athlete who wins the Tokyo Marathon can earn tens of thousands of dollars just to show up. Three runner-up finishes at majors means she is in the group every organizer wants. A six-year ban wipes out that entire income stream. Not just for six years — but possibly forever, because at 38, even if eligible to race again, she will no longer be the name organizers are willing to pay for. There are players who never make the front page, but score goals in my heart. Aga is not in that group — she has been on the front page. But she belongs to another group: women athletes whose careers collapse not because they lacked talent, but because they lacked someone standing beside them telling them the truth at the right moment. Let us talk about the Ethiopian marathon system. Ethiopia and Kenya are the two undisputed powers of distance running. At the top, they are roughly equal. But what is more remarkable is their depth — what I call the bench. When one Ethiopian athlete is banned, the system does not waver. There are ten others ready to step into that position, many younger, hungrier, and possibly faster. That means Aga's case has almost no effect on the competitive balance of women's world marathon. She is a replaceable node in an extraordinarily deep production line. But it does affect something else: the reputational value of the Ethiopian marathon brand. And that brand value is real — it is why race organizers worldwide are willing to pay top money for Ethiopian athletes, trusting they bring both performance and story. A case like this, however individual, still scratches the gloss a little. But I want to be careful here. There is a strong temptation to turn Aga's case into a story about "Ethiopia's systemic problem." I do not believe that reading. What we see here is not an organised doping programme, not a state-level conspiracy, not a network of doctors and agents covering up together. What we see is one woman, one family, one old prescription pad, and one clinic that does not exist. That is amateurism, not system. And equating it with a national problem would be an injustice to the thousands of Ethiopian athletes competing cleanly every day. The pandemic locked the stadium gates, but it could not lock away the old footage. I remember sitting in the station archive, reviewing matches and races no one remembered, and realising that the history of women's sport is full of forgotten stories — not because they were unimportant, but because no one bothered to dig. Aga's case is the same. Read only the headline, and it is a doping story. Dig deeper, and it is a story about support structures, about the difference between a prohibited substance and a forged document, about how a system can protect or abandon a person. And this is where I want to offer a view I consider counter-intuitive. When this case was announced, the natural public reaction was outrage. "Another doping athlete." But if you read the file carefully, we see something almost the opposite: this may be a case where the doping conduct — in the sense of taking a substance to enhance performance — barely occurred. Methylprednisolone does not make you run faster. It is an anti-inflammatory. It helps a sore knee swell less. If Aga genuinely had a knee injury and was genuinely treated, her error was not deliberate cheating, but using a substance prohibited in-competition without a permit. That is an administrative mistake, not a moral crime. But then she turned it into a crime. By fabricating. This is what I want to say as someone who has followed women's sport for nearly twenty years: we tend to judge women athletes more harshly than men for the same error. When a male athlete uses a corticosteroid for an injury, the story is usually told as a medical accident. When a female athlete does the same, the story tends to slide toward "she cheated." I do not have data to prove this scientifically — and I will not pretend to. But I have nearly twenty years of observation, and I see a pattern: women athletes, especially those from less-invested sports, are often treated with less understanding when they make mistakes. But again, I must check myself. If I only say "Aga is a victim," I ignore the truth that she chose to fabricate. If I only say "Aga is a cheat," I ignore the truth that the system abandoned her. The truth lies in between, and it is more uncomfortable than either side. Let us look ahead. Six years is a long time. Realistically, Aga will not return to the top. She will likely retire, though perhaps without an official announcement. Her case will go into the record as one of the heaviest sanctions in women's marathon in this decade — not because of the substance, but because of the forged documents. But there is a larger question this case raises, and it is not only for Aga. How is a 32-year-old Ethiopian athlete, making a living running road races across Asia, supposed to know that the painkilling injection she received in her knee after a race is prohibited in-competition? How is she supposed to know she needs a TUE? How is she supposed to know that if she tests positive, she should tell the truth instead of trying to cover it up? The answer is: she needs someone to tell her. And in the current system, that someone often does not exist. I do not say this to lessen her responsibility. I say it because I believe sport has a responsibility to the very people who make it. If we require athletes to comply with a complex set of rules, we must give them the tools to understand those rules. Otherwise we are not building a fair system. We are only building a system that catches people who lack the means to protect themselves. There is a small detail in the file I keep thinking about. The relative who signed that prescription — the person who claimed to be a doctor, used an old pad, lied about a former workplace. I do not know who that person is. I do not know their relationship with Aga. But I know one thing: they tried to help her, and they destroyed her. That is the tragedy of people who lack expertise but have enough affection to act. They thought a piece of paper would be enough. They did not know the AIU needed only three phone calls to tear it apart. The most valuable mistake of mine was thinking I had to be perfect on camera. I once thought that in sport there are only two states: right and wrong. But over the years, through stories like Aga's, I have understood that most cases sit in the grey zone — where a small mistake, a gap in support, a hasty decision can turn a career into a file. And here is what I want to leave you with. Women's sport, especially in cultures that receive little attention, is in a period of transformation. Athletes are earning more, being seen more, being celebrated more. But that transformation has not come with matching support infrastructure — legal, medical, anti-doping education. Ruti Aga's case is not a stain to be forgotten. It is a reminder that: when a woman athlete falls, the question we need to ask is not only "what did she do wrong," but also "who was not there to help her do right." Under the dust of old seasons, there are matches that never fell silent. And sometimes the loudest echo comes from an old prescription pad — something that should never have needed to exist, if only one call had been made at the right time.